Driving Growth in the Ablation Technology Market: Industry Trends and Forecast Through 2029

Comments · 2 Views

Johnson & Johnson (US) received CE mark approval for the VARIPULSE Pulse Field Ablation Platform that helps visualize real-time and enhances workflow.

The global Ablation Technology Market growth forecasted to transform from USD 6.11 billion in 2024 to USD 9.62 billion by 2029, driven by a CAGR of 9.5%. The drivers for this market include expanding access to healthcare services, an increasing preference for minimally invasive treatments, and the use of ablation procedures in expanded application fields that fuel the ablation technology market growth. Additionally, factors such as a growing number of public campaigns to increase awareness related to early detection, a rise in global healthcare expenditure, and supportive reimbursement policies further contribute to the growth of the ablation technology market. The ablation technology market has experienced a surge on the global level due to lucrative opportunities offered by emerging countries such as India and China. Furthermore, factors such as the expansion of the private healthcare sector and increasing patient population drive the adoption of ablation solutions in the end user facilities.

Download PDF Brochure

Browse in-depth TOC on "Ablation Technology Market"

226 - Tables
64 - Figures
290 – Pages

Driver: Emerging ablation technologies

Pulse-field ablation (PFA) is a potentially effective technique for treating cardiac diseases. This non-thermal technique offers a tissue selectivity feature and protects neighboring tissues from harm. PFA for arrhythmias has produced encouraging findings in most preclinical and clinical studies. Additionally, growing R&D expenditure, promoting clinical trials, and recently approved products have increased the market need for this technology. In 2024, Bio Sense Webster, a division of Johnson & Johnson (US), announced that VARIPULSE had received European CE approval for using pulsed-field ablation to treat symptomatic drug-refractory recurrent paroxysmal atrial fibrillation.

Pulsed field ablation segment to register significant growth rate over the forecast period of 2024-2029.

Based on the technology, the global ablation technology market is further segmented into Radiofrequency ablation, Laser/Light ablation, Ultrasound ablation, Electrical ablation, Cryoablation ablation, Microwave ablation, Pulsed field ablation, and Hydrothermal/Hydromechanical ablation. Pulsed field ablation held to register highest growth rate over forecast period due to its potential to use in cardiovascular disease treatment, technological advancements, and product launches and approvals by the major players,

Consumables segment to register significant growth rate over the forecast period of 2024-2029.

Based on the product, the global ablation technology market is further segmented into systems and consumables. The consumables segment is anticipated to register the highest growth rate during the forecast period. Availability of technologically advanced consumables in the market supporting improved patient safety, integration of AI, and rising focus on non-invasive treatment approaches contribute to the expanding utilization of consumables within various healthcare facilities.

Cardiovascular disease treatment segment in application to register a significant growth over the forecast period of 2024-2029

Based on application, the global ablation technology market is segmented by application into cardiovascular disease treatment, cancer treatment, orthopedic treatment, cosmetic/aesthetic treatment, urological treatment, gynecological treatment, pain management, ophthalmological treatment and other applications. The growing trend towards use of ablation devices due to improved patient outcomes and increased spectrum of heart conditions that can be treated using ablation has driven the growth of cardiovascular disease treatment application. Rising healthcare expenditure and increasing prevalence of atrial fibrillation on the global level supports the highest growth rate of the segment.

Request Sample Pages

Ambulatory surgical centers are expected to register highest growth rate over the forecast period of 2024-2029

Based on end users, the ablation technology market is segmented into hospitals, surgical centers, and ablation centers, ambulatory surgery centers, medical spas and aesthetic & dermatology clinics, and other end users. Ambulatory surgery centers provide lower cost treatment than hospitals. Factors such as quick recovery time in ablation procedure and lower patient co-pays contributes to the rising growth of the segment.

The Asia pacific market will register significant growth during the forecast period of 2024-2029

The Asia Pacific ablation technology market is estimated to register significant growth from 2024 to 2029. Increasing target patient population, rising investments by the major players, and growing disposable income to fuel the adoption of ablation technology equipment in the region. Moreover, the Asia pacific region has experienced a rise in investments by governments and major players, offering significant growth opportunities.

Recent Developments of Ablation Technology Market

  • In February 2024, Johnson & Johnson (US) received CE mark approval for the VARIPULSE Pulse Field Ablation Platform that helps visualize real-time and enhances workflow.
  • In December 2023, Medtronic (US) approved a Pulse Select Pulsed Field Ablation System that helps treat persistent and paroxysmal atrial fibrillation.

For more information, inquire now! Inquire Now

Content Source:

https://www.prnewswire.com/news-releases/ablation-technology-market-worth-9-62-billion-by-2029-driven-by-emerging-tech-innovations--marketsandmarkets-302229344.html

https://www.marketsandmarkets.com/Market-Reports/ablation-devices-market-791.html

https://www.marketsandmarkets.com/PressReleases/ablation-technology.asp

Comments